CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 164 filers reported holding CARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $231 | +108.1% | 81,688 | +262.5% | 0.02% | +109.1% |
Q1 2023 | $111 | -100.0% | 22,534 | -81.3% | 0.01% | -93.3% |
Q2 2022 | $1,100,000 | +619.0% | 120,533 | +859.4% | 0.16% | +685.7% |
Q1 2022 | $153,000 | -51.0% | 12,564 | -26.3% | 0.02% | -50.0% |
Q3 2019 | $312,000 | -4.6% | 17,048 | -56.5% | 0.04% | +133.3% |
Q3 2016 | $327,000 | -6.0% | 39,200 | -30.0% | 0.02% | -18.2% |
Q1 2016 | $348,000 | -77.3% | 56,019 | -38.5% | 0.02% | -70.7% |
Q4 2015 | $1,535,000 | +52.7% | 91,073 | +29.5% | 0.08% | +53.1% |
Q3 2015 | $1,005,000 | +848.1% | 70,319 | +563.4% | 0.05% | +600.0% |
Q4 2014 | $106,000 | -36.1% | 10,600 | -46.5% | 0.01% | -22.2% |
Q3 2014 | $166,000 | – | 19,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |